Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.

Résumé

The lastly identified claudin-low (CL) subtype of breast cancer (BC) remains poorly described as compared to the other molecular subtypes. We provide a comprehensive characterization of the largest series of CL samples reported so far.